Faculty of Medicine
Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14
Browse
3 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, INFLUENCE OF BMI ON RESISTIN IN GDM AND NORMOGLYCEMIC WOMEN(SHMSHM - AAMD, 2020-01-25); ; ; ;Bogoev, MilchoBogoeva, KsenijaBackground: Gestational diabetes melitus is a glucose intolerance which is diagnosed for the first time in pregnancy. It may lead to potentially serious short term and long term maternal, fetal and neonatal complications. In GDM pregnancies biomarkers like resistin are elevated and may provide informations on pathophysiology and prediction of perinatal risk. Aim: to evaluate the average concentration of resistin in GDM and normoglycemic women, influence of body mass index on concentration of resistin in GDM and normoglycemic women. Material and methods: Case control study was made at the University Clinic for obstetrics and gynecology, Skopje in a period of one year. 100 pregnant women were regruted from the pregnant women that performed 75g OGTT in the second trimester for sreening for gestational diabetes melitus. Body mass index was calculated according to the terms of Institute of medicine and pregnant women were divided in 4 groups: GDM BMI>25 (n=25), GDM BMI<25(n=25), normoglycemic BMI>25(n=25), normoglycemic BMI<25(n=25). Serum levels of resistin were analysed with ELISA method. Results: The average values of resistin in GDM were 3.15 ± 2.02 ng/ml vs 1.94 ± 0.8 ng/ml in the control group, p=0.00021. In GDM, BMI>25 average values of resistin were 3.15 ± 2.0, whereas in GDM, BMI<25 resistin was significantly lower, 1.94 ± 0.8, p=0.0003. Pregnant women with GDM and BMI>25 had significantly higher average values of resistin (3.16 ± 2.2 ng/ml vs 2.09 ± 0.7 ng/ml, p=0.029) than normoglycemic women with BMI>25. Also pregnant women with GDM, BMI<25 had significantly higher values of resistin than normoglycemic pregnant women with BMI<25 (3.14±1.8 ng/ml vs 1.77±0.9 ng/ml), p=0.003. Normoglycemic overweight women had insignificantly higher values of resistin vs normoglycemic women with normal weight (2.09 ± 0.7 ng/ml vs 1.78 ± 0.9 ng/ml; p=0.19). Conclusion: The results from the study confirmed that GDM significantly alters the values of resistin. In the group of pregnant women with GDM the values of resistin are significantly elevated in women with BMI>25 vs BMI<25. Both women with GDM, BMI>25 and GDM, BMI<25 had significantly higher resistin than normoglycemic women with same BMI. In normoglycemic pregnant women resistin does not have a significant correlation with BMI. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study(Mary Ann Liebert Inc, 2011-11); ;Dimitrovski, Cedomir ;Bogoev, Milcho; The aim of the study is to describe glycemic and insulin outcomes by trimester and maternal and fetal outcome in patients with type 1 diabetes using an insulin pump with constant or intermittent continuous glucose monitoring (CGM). - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Influence of metabolic dysregulation in pre ulcerative phase of diabetic foot(2012); ;Bogoev, Milcho; ; Aim. To estimate the impact of metabolic disturbances in type 2 diabetic patients (T2DM) – glucose regulation, obesity, dyslipidemia, hypertension and risk for ulceration in the preulcerative phase of the diabetic foot syndrome (DFS). Materials and methods. In this prospective study 100 T2DM patients were evaluated for 1 year. The following parameters were estimated: duration, smoking habits, BMI, BP, HbA1c, TG, HDL, LDL, fundoscopy and measurements for risk score of DFS. Groups were stratified according to measurements : 0 – low risk, 1 – medium risk, 2- high risk, and 3 – very high risk. Results. Out of 100 patients, 53% were female and 47% male. Mean duration of T2DM was 10.47 ± 4.77 years. Diabetes duration up to 10 years included 52% of subjects and 48 % had a duration of more than 10 years. Forty-three percent were smokers , of which 77.4% were male and 22.6% female. Results of measurements for risk score stratifications are in visit 1 (V1): score 0 - 29 %, score 1 – 35%, score 2-18% and score 3 – 18% and after 12 months in visit 2 (V2) score 0- 17 %, score 1 – 39%, score 2-19% and score 3 – 25%. BMI was recorded as follows: normal (18 -25 kg/m2) 14%, overweight (25-30 kg/m2) 71% and obese (>30 kg/m2) 15% of patients. Mean HbA1c in V1 according the risk score is: 0 - =7.6%, 1- 7.9%, 2 – 8.5% and 3- 8.2% (p<0,005), and in V2: score 0- 7.26%, score 1-7.46%, score 2-7.54% and score 3-7.54%. Systolic BP categorical scores were measured: score 0 – 136 mmHg, 1 – 142 mmHg, 2 – 145 mmHg, 3 – 142 mmHg. Mean levels of TG scores were: 0-1.97 mmol/L, 1- 2.37 mmol/L, 2- 2.3 mmol/L, 3- 2.6 mmol/L. Mean levels of HDL: 0 – 1.06 mmol/L, 1 – 1.02 mmol/L, 2 – 0.97 mmol/L, 3 – 1,00 mmol/L. Mean levels of LDL: 0 – 3.69 mmol/L, 1 – 4.27 mmol/L, 2 – 4.05 mmol/L 3 – 4.09 mmol/L. Diabetic retinopathy (DR) in V1 was present with 68% - 53% non proliferative and 15% proliferative. In V2, DR was present in 72% of which 51% was nonproliferative and 21% proliferative. Conclusion: Suboptimal management of T2DM – high HbA1c, high BP, High TG and high LDL, are multiple factors for early appearance of DFS and have the impact of early progression from low to high score for foot ulceration. In T2DM, patients with duration more than 10 years , HbA1c>8%, TG>2.2 mmol/L, HDL<1.04 mmol/L , LDL>4 mmol/L have a high risk (2) or very high risk (3) score for ulceration.
